tirzepatide and semaglutide tablets & Tirzepatide: Can You Combine Them? Weekly GLP-1 Injection vs Daily

Mounjaro (Tirzepatide) Injection 7.5 mg/0.5 mL Prefilled Syringes are a type of medication used to treat type 2 diabetes. They contain the active ingredient tirzepatide, which belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. This medication is delivered as a pre-filled syringe that contains 7.5 mg of tirzepatide in a solution of 0.5 mL. It is given as a subcutaneous injection (under the skin) once a week and works by mimicking the function of a naturally occurring hormone in the body called GLP-1, which helps regulate blood sugar levels. Mounjaro is intended to be used in conjunction with a healthy diet and exercise to help control blood sugar in adults with type 2 diabetes. It may also help in weight management for people with obesity or overweight. As with any medication, it is important to follow the instructions of a healthcare professional and to report any side effects experienced

Your provider will determine the correct dose for you based on your treatment goals and how you tolerate the medication

Following the set medication times also helps it work better to manage body weight effectively

Tirzepatide mimics two naturally occurring gut hormones, GIP and GLP-1, that are released after eating

For best handling practices, researchers commonly store peptide products in cool, dry conditions away from direct sunlight and moisture

Patients may find it easier to consume protein shakes during the latter part of their dosing week when nausea has subsided and appetite begins to return slightly